1. Home
  2. ZTS vs SYF Comparison

ZTS vs SYF Comparison

Compare ZTS & SYF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zoetis Inc.

ZTS

Zoetis Inc.

SELL

Current Price

$75.07

Market Cap

29.0B

Sector

Health Care

ML Signal

SELL

Logo Synchrony Financial

SYF

Synchrony Financial

SELL

Current Price

$71.77

Market Cap

24.7B

Sector

Finance

ML Signal

SELL

Company Overview

Basic Information
Metric
ZTS
SYF
Founded
1952
1932
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
29.0B
24.7B
IPO Year
2012
2014

Fundamental Metrics

Financial Performance
Metric
ZTS
SYF
Price
$75.07
$71.77
Analyst Decision
Buy
Buy
Analyst Count
17
24
Target Price
★ $94.86
$87.96
AVG Volume (30 Days)
★ 2.9M
2.6M
Earning Date
11-05-2026
10-20-2026
Dividend Yield
★ 2.85%
1.85%
EPS Growth
★ 10.05
8.54
EPS
3.08
★ 4.85
Revenue
★ $9,467,000,000.00
N/A
Revenue This Year
N/A
$1.24
Revenue Next Year
$2.59
$5.47
P/E Ratio
$24.12
★ $15.17
Revenue Growth
★ 2.28
N/A
52 Week Low
$68.92
$63.08
52 Week High
$148.30
$88.77

Technical Indicators

Market Signals
Indicator
ZTS
SYF
Relative Strength Index (RSI) 58.71 41.80
Support Level $73.93 $71.25
Resistance Level $78.20 $74.80
Average True Range (ATR) 1.62 1.42
MACD 0.67 0.27
Stochastic Oscillator 87.91 47.62

Price Performance

Historical Comparison
ZTS
SYF

About ZTS Zoetis Inc.

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

About SYF Synchrony Financial

Synchrony Financial, originally a spinoff of GE Capital's retail financing business, is the largest provider of private-label credit cards in the United States by both outstanding receivables and purchasing volume. Synchrony partners with other firms to market its credit products in their physical stores as well as on their websites and mobile applications. Synchrony operates through three segments: retail card (private-label and co-branded general-purpose credit cards), payment solutions (promotional financing for large ticket purchases), and CareCredit (financing for elective healthcare procedures).

Share on Social Networks: